Skip to main content
Robert Belshe, MD, Infectious Disease, Saint Louis, MO

RobertBBelsheMD

Infectious Disease Saint Louis, MO

Microbiology

Professor, Internal Medicine, St Louis University School of Medicine

Dr. Belshe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Belshe's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1975 - 1978
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1973
  • William & Mary
    William & MaryBS, Chemistry, Minor in Math, 1966 - 1970

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1974 - Present
  • MO State Medical License
    MO State Medical License 1989 - 2025
  • WV State Medical License
    WV State Medical License 1978 - 1989
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Certificate of Appreciation The Biomedical Advanced Research and Development Authority (BARDA), 2014
  • Grant Winner Award for Excellence in Research Saint Louis University, 2011
  • Heroes Lifetime Achievement Award St. Louis Business Journal Health Care, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial  
    Ledgerwood JE, Bellamy AR, Belshe RB, Bernstein DI, Edupuganti S, Patel SM, Renehan P, Zajdowicz T,Schwartz R, Koup R, Bailer RT, Yamshchikov GV, Enama ME, Sarwar U..., PLOS ONE, 1/7/2015
  • Prolonged Pro-Inflammatory Cytokine Production in Monocytes Following Influenza Vaccination is Modulated by IL-10 in Older Adults  
    Mohanty S, Joshi SR, Ueda I, Wilson J, Blevins T, Siconolfi B, Meng H, Devine L, Raddassi K, Tsang S, Belshe RB, Hafler DA, Kaech SM, Kleinstein S H, Trentalange M, Al..., J Infect Dis, 1/2/2014
  • Progress toward the Development of Universal Influenza Vaccines  
    Hoft DF, Belshe RB, Missouri Medicine, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Efficacy of Live Attenuated Influenza Vaccine against Moderate to Severe versus Mild Influenza Illness in Children
    Ambrose C, Belshe RB., Pediatric Academic Societies’ Annual Meeting, Washington, DC, 1/4/2013
  • Safety and Immune Responses in Children Ages 6 Months through 17 Years after Administration of Concurrent and Sequential Sanofi Pasteur’s 2009 H1N1 Vaccine and 2009-20...
    Frey SE, Bernstein DI, Gerber MA, Keyserling HL, Munoz FM, Winokur P, Turley CB, Hill H, Belshe RB, 48th Annual Meeting of the Infectious Diseases Society of America (IDSA), Vancouver, BC, Canada, 1/21/2010
  • Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
    Ray R, Meyer K, Banerjee A, Basu A, Coates S, Abrignani S, Houghton M, Frey SE, Belshe RB, 17th International Meeting on Hepatitis C Virus and Related Viruses (HCV 2010), Yokohama, Japan, 1/11/2010
  • Join now to see all

Lectures

  • Pandemic Influenza: Science to Policy 
    1/1/2006
  • Influenza Virus Infection: Immunity and Mucosal Vaccines 
    University at Buffalo – The State University of New York - 1/1/2003
  • Rhesus Rotavirus: A Candidate Vaccine for Prevention of Human Rotavirus Disease 
    1/1/1984
  • Join now to see all

Other

  • A 4-Year-Old Boy With a History of Mild Wheezing. Patient Case Study 
    Belshe RB, myCME, Haymarket Medical Education
    1/1/2014
  • Meeting the Challenge of Respiratory Syncytial Virus Infections 
    Belshe RB, Checchia PA, Vindico Medical Education, Infectious Diseases in Children
    1/1/2013
  • Influenza Vaccination in Children: Efficacy and Effectiveness. 
    Belshe RB, Vaccinating Schoolchildren: Next Step Forward in the Battle against Influenza?, 27th Annual Meeting
    Brussels, Belgium - 1/31/2010
  • Join now to see all

Press Mentions

  • BioSpace Movers & Shakers, Aug. 27
    BioSpace Movers & Shakers, Aug. 27August 27th, 2021
  • Vaxart Announces Creation of New Scientific and Clinical Advisory Board
    Vaxart Announces Creation of New Scientific and Clinical Advisory BoardAugust 19th, 2021
  • Influenza Vaccine: FluGen Demonstrates Vaccine-Induced Protection Against a Highly Drifted H3N2 Influenza Virus in a Human Challenge Study
    Influenza Vaccine: FluGen Demonstrates Vaccine-Induced Protection Against a Highly Drifted H3N2 Influenza Virus in a Human Challenge StudyAugust 2nd, 2021
  • Join now to see all

Grant Support

  • Career Development Award In Biodefense And Emerging Infectious Diseases ResearchNational Institute Of Allergy And Infectious Diseases2009–2012
  • Vaccine And Treatment Evaluation UnitsNational Institute Of Allergy And Infectious Diseases2009
  • Innate And Adaptive Immunity To MVANational Institute Of Allergy And Infectious Diseases2008
  • Evaluation Of Control Measures Against Diseases Other THAN AIDSNational Institute Of Allergy And Infectious Diseases2007
  • HIV Vaccine Clinical Trial Unit At Saint Louis UniverNational Institute Of Allergy And Infectious Diseases2001–2006
  • HIV Vaccine Clinical Trial Unit At Saint Louis UnivNational Institute Of Allergy And Infectious Diseases2000
  • Control Measures In Aging And Infectious DiseaseNational Institute Of Allergy And Infectious Diseases1994–2000
  • AIDS Vaccine Evaluation UnitsNational Institute Of Allergy And Infectious Diseases1994–2000
  • Control Of Human Infectious Diseases Other THAN AIDSNational Institute Of Allergy And Infectious Diseases1994
  • Control Measures Against Infect Disease Other THAN AIDSNational Institute Of Allergy And Infectious Diseases1994
  • AIDS Vaccine Evaluation UnitNational Institute Of Allergy And Infectious Diseases1990–1994
  • Cntl Measures Against Human Infec Disease Other THAN AIDNational Institute Of Allergy And Infectious Diseases1990–1993
  • Control Measure--Human Infectious Disease Excluding AIDSNational Institute Of Allergy And Infectious Diseases1990